EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment
Public ClinicalTrials.gov record NCT06386874. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Efficacy of a Frequency-tuned Electromagnetic Field Treatment in Facilitating the Recovery of Subacute Ischemic Stroke Patients - a Pivotal Study (the "EMAGINE 2.0" Study)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter study that will be conducted at approximately 20 centers and up to 30 centers, if the sample size will be increased following interim assessment. The Q Therapeutic System (BQ 3.0) is a wearable medical device that produces and delivers non-invasive, extremely-low-intensity and low-frequency, frequency-tuned electromagnetic fields in order to stimulate neuronal networks with the aim of reducing disability and promoting neurorecovery. The Q Therapeutic System (BQ 3.0) is indicated for adjunctive use in a clinical facility or home setting, in addition to standard-of-care therapies. * In Stage 1 (starting 4-21 days after the index stroke event to day 90 post stroke), participants will be randomly assigned (1:1) to receive either active or the sham treatments, up to 5 times a week, and at least to a total of 45 treatments. * In Stage 2 (day 90 to day 180 post stroke), participants in both the active and the control group will be allowed to continue to receive active treatments, up to 5 times per week. * In stage 3 (day 180 to day 270 post stroke), participants will not receive any treatments and would be followed up until the final visit at day 270. Each session will last approximately 60 minutes, with stimulation activated for up to 40 minutes, in conjunction with a home-based exercise program. Treatments may be administered in the hospital, in the clinic or in a home setting. The study will enroll 100-122 adult subjects who will be randomly assigned (1:1 allocation ratio) to either active or sham study intervention using the BQ 3.0 system.
Study identification
- NCT ID
- NCT06386874
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 122 participants
Conditions and interventions
Conditions
Interventions
Device
Eligibility (public fields only)
- Age range
- 22 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 20, 2024 (Actual)
- Primary completion
- Jul 2026 (Estimated)
- Completion
- Oct 2026 (Estimated)
- Last update posted
- Jan 9, 2025
2024 – 2026
United States locations
- U.S. sites
- 14
- U.S. states
- 12
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rancho Research Institute | Downey | California | 90242 | Recruiting |
| MedStar National Rehabililtaion Hospital, | Washington D.C. | District of Columbia | 20010 | Recruiting |
| Brooks Rehabilitation Hospital | Jacksonville | Florida | 32216 | Not yet recruiting |
| Emory University School of Medicine | Altanta | Georgia | 30322 | Not yet recruiting |
| Shirley Ryan AbilityLab | Chicago | Illinois | 60611 | Not yet recruiting |
| KUMC- KU Medical Center | Kansas City | Kansas | 66160 | Recruiting |
| Hackensack Meridian JFK Johnson Rehabilitation Institute | Edison | New Jersey | 08818 | Recruiting |
| Kessler Foundation for Rehabilitation | West Orange | New Jersey | 07052 | Recruiting |
| New York-Presbyterian Brooklyn Methodist Hospital Inpatient Rehabilitation Unit | Brooklyn | New York | 11215 | Not yet recruiting |
| Burke Rehabilitation Hospital | White Plains | New York | 10605 | Recruiting |
| Atrium Health Carolinas Rehabilitation | Charlotte | North Carolina | 28203 | Recruiting |
| Moss Rehabilitation Research Institute | Elkins Park | Pennsylvania | 19027 | Not yet recruiting |
| UTHealth Houston | Houston | Texas | 77030 | Not yet recruiting |
| Froedtert & Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06386874, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 9, 2025 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06386874 live on ClinicalTrials.gov.